Transcatheter Aortic Valve Replacement Market Size 2024-2028

The global Transcatheter Aortic Valve Replacement (TAVR) market is projected to grow by USD 2.40 billion, with a CAGR of 6.78% between 2023 and 2028. This growth is attributed to the expanding aging population and the increasing prevalence of heart diseases that require valve replacement. Additionally, TAVR procedures are becoming more widely adopted for patients who are not suitable candidates for traditional surgery. However, the high costs associated with these procedures remain a key challenge for patient access.

For more details about the industry, get the PDF sample report for free

Market Segmentation

The TAVR market is segmented by end-user, type, and geography:

End-user:

• Hospitals
• Ambulatory Surgical Centers
• Others

Type:

• Balloon-Expanding Valve
• Self-Expanding Valve

Geography:

• North America
  • US
• Europe
  • Germany
  • UK
  • France
• Asia
  • China
• Rest of World (ROW)

By End-user Insights

The hospital segment is expected to witness significant growth, primarily due to the advanced facilities available for interventional cardiology procedures. Hospitals are equipped with specialized technologies such as echocardiography, fluoroscopy, and cardiac catheterization that ensure precise TAVR procedures. The advanced infrastructure in hospitals, including imaging systems like CT and MRI, is crucial for the safety and effectiveness of TAVR treatments.

Regional Insights

The North American market is forecast to contribute 39% to the global TAVR market growth from 2024 to 2028. The increasing prevalence of heart valve diseases and the rapidly aging population in the US and Canada are driving this growth. Technological advancements, including the rising use of suture-less valves and minimally invasive procedures, further boost market demand. The US remains the dominant player in the global TAVR market, benefiting from advanced healthcare infrastructure and a significant aging population.

Market Dynamics

Market Drivers:

1. Aging Population: The growing elderly population, particularly those over 65, is driving the demand for TAVR procedures. By 2050, 16% of the global population will be aged 65 or above, making aortic valve diseases, such as aortic stenosis, more prevalent and boosting the need for TAVR treatments.
2. Minimally Invasive Nature of TAVR: Unlike traditional open-heart surgery, TAVR offers a less invasive option, reducing recovery time and hospital stays. It is particularly beneficial for high-risk patients, including those with rheumatic heart disease or bicuspid aortic valve.

Market Trends:

1. Expansion of TAVR Indications: The eligibility criteria for TAVR are expanding, with clinical evidence supporting its safety and efficacy. Previously limited to high-risk patients, TAVR is now being considered for a broader patient group, including those with rheumatic heart disease and bicuspid aortic valve.

Get more details by ordering the complete report

Market Challenges:

1. High Costs: The high cost of TAVR procedures is a significant barrier to market growth, even with insurance coverage. The expense of TAVR devices remains a key challenge, limiting accessibility for some patients. Despite this, innovations like Heart Valve CareLine are aiming to reduce these costs by offering comprehensive valve solutions.

Key Companies & Market Insights

Companies are focusing on various strategies, including partnerships, mergers, acquisitions, and geographical expansions, to strengthen their position in the TAVR market. Key players in the market include:

• 4C Medical Technologies Inc.
• Abbott Laboratories
• Anteris Technologies Ltd.
• Artivion Inc.
• Biosensors International Group Ltd.
• Boston Scientific Corp.
• Colibri Heart Valve LLC
• Edwards Lifesciences Corp.
• Genesis Medtech International Pvt. Ltd.
• HighLife SAS
• JenaValve Technology Inc.
• LifeNet Health Inc.
• LivaNova PLC
• Medinol Ltd.
• Medtronic Plc
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corp.
• Shockwave Medical Inc.
• Siemens AG
• Venus Medtech Hangzhou Inc.

Future Market Insights

The TAVR market is expected to continue growing as technological advancements reduce costs and expand the availability of these life-saving procedures to a broader patient population.